Simple blood test may predict Parkinson's progression

NCT ID NCT07163156

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether prolactin (a hormone) and certain inflammation markers in the blood are linked to how severe Parkinson's disease is. Researchers will measure these in 300 people with Parkinson's and compare them to standard disease severity scores. The goal is to find simple, non-invasive ways to monitor the disease over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could point toward simple blood or saliva tests to help monitor Parkinson's progression.

What could go wrong

This is an early observational study, not a treatment trial. It may find no clear link, and results may not apply to all Parkinson's patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperprolactinemia Inflammation inflammatory disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Çanakkale Onsekiz Mart University

    Çanakkale, Merkez, 17020, Turkey (Türkiye)